Literature DB >> 1334186

Proton relaxation enhancement by means of serum albumin and poly-L-lysine labeled with DTPA-Gd3+: relaxivities as a function of molecular weight and conjugation efficiency.

M Spanoghe1, D Lanens, R Dommisse, A Van der Linden, F Alderweireldt.   

Abstract

A series of poly-L-lysine chains, with molecular weight ranging from 3300 up to 102,000 Da, were labeled with DTPA-Gd3+. No significant differences in longitudinal and transversal relaxivity, could be demonstrated as a function of the chain length. The R1 and R2 relaxivities were respectively 2.5 and 5 times superior to those of plain DTPA-Gd3+ (at 2.4 T). Bovine serum albumin was also labeled in a way that a wide (DTPA-Gd3+)/BSA range (3-39) was obtained. The longitudinal relaxivity, of these paramagnetically labeled albumins, increased with increasing (DTPA-Gd3+)/BSA ratios. This effect was most pronounced at very low (DTPA-Gd3+)/BSA ratios.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334186     DOI: 10.1016/0730-725x(92)90445-6

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  8 in total

Review 1.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Lectin conjugates as biospecific contrast agents for MRI. Coupling of Lycopersicon esculentum agglutinin to linear water-soluble DTPA-loaded oligomers.

Authors:  Irena Pashkunova-Martic; Christian Kremser; Markus Galanski; Petra Schluga; Vladimir Arion; Paul Debbage; Werner Jaschke; Bernhard Keppler
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

3.  Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence.

Authors:  Lindsay S Karfeld-Sulzer; Emily A Waters; Nicolynn E Davis; Thomas J Meade; Annelise E Barron
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

Review 4.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

5.  Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents.

Authors:  Sang Young Jeong; Hyo Jeong Kim; Byung-Kook Kwak; Ha-Young Lee; Hasoo Seong; Byung Cheol Shin; Soon Hong Yuk; Sung-Joo Hwang; Sun Hang Cho
Journal:  Nanoscale Res Lett       Date:  2010-09-02       Impact factor: 4.703

Review 6.  Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Authors:  Zhuxian Zhou; Zheng-Rong Lu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-10-09

Review 7.  Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Authors:  Zhibo Liu; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

8.  Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?

Authors:  Joshua Bryson; Jeffrey W Reineke; Theresa M Reineke
Journal:  Macromolecules       Date:  2012-11-13       Impact factor: 5.985

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.